News
10d
Zacks Investment Research on MSNTEVA Stock Up More than 20% in Three Months: Buy, Sell or Hold the Stock?
Teva Pharmaceutical Industries Limited’s TEVA shares have risen 21.6% in three months. Over the past few quarters, Teva has ...
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the most promising stocks according to Wall Street analysts. On ...
11d
Barchart on MSNTeva Pharmaceutical (TEVA) Just Flashed a Statistically Viable Signal for Bullish Traders
Bold speculators interested in a quick strike may want to set their sights on healthcare specialist Teva Pharmaceutical ...
NYSE:TEVA opened at $16.18 on Wednesday. The company has a 50-day moving average of $17.79 and a 200-day moving average of $18.21. The firm has a market cap of $18.34 billion, a price-to-earnings ...
Teva Pharmaceutical Industries stock opened at $15.68 on Thursday. Teva Pharmaceutical Industries has a 12-month low of $12.51 and a 12-month high of $22.80. The company has a current ratio of 0. ...
What happened. Shares of the Israeli generic drug giant Teva Pharmaceutical Industries (TEVA 2.93%) are poised for a strong session Wednesday. The drugmaker's stock jumped by as much as 20.4% in ...
Teva Pharmaceutical Industries Ltd. announced that it will release its second quarter 2025 financial results on July 30, 2025, at 7:00 a.m. ET, followed by a conference call and live webcast at 8: ...
On Tuesday, Teva Pharmaceutical Industries (TEVA 1.30%) was one of the few large-cap stocks to rise in price on a terrible day for the stock market.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results